Day: October 8, 2021

S100A4/non-muscle myosin II signaling regulates epithelial-mesenchymal transition and stemness in uterine carcinosarcoma.

S100A4/non-muscle myosin II signaling regulates epithelial-mesenchymal transition and stemness in uterine carcinosarcoma.S100A4/non-muscle myosin II signaling regulates epithelial-mesenchymal transition and stemness in uterine carcinosarcoma.

Uterine carcinosarcoma (UCS) represents a real instance of most cancers related to epithelial-mesenchymal transition (EMT), which displays most cancers stem cell (CSC)-like traits. Though S100A4 is an inducer of EMT, little is

Linker engineering in anti-TAG-72 antibody fragments optimizes biophysical properties, serum half-life, and high-specificity tumor imaging.

Linker engineering in anti-TAG-72 antibody fragments optimizes biophysical properties, serum half-life, and high-specificity tumor imaging.Linker engineering in anti-TAG-72 antibody fragments optimizes biophysical properties, serum half-life, and high-specificity tumor imaging.

Antibody (Ab) fragments have nice medical potential as most cancers therapeutics and diagnostics. Their small measurement permits for quick clearance from blood, low immunoreactivity, higher tumor penetration, and less complicated

Vimseltinib: A precision CSF1R therapy for tenosynovial giant cell tumors and diseases promoted by macrophages

Vimseltinib: A precision CSF1R therapy for tenosynovial giant cell tumors and diseases promoted by macrophagesVimseltinib: A precision CSF1R therapy for tenosynovial giant cell tumors and diseases promoted by macrophages

Macrophages will be co-opted to contribute to neoplastic, neurologic, and inflammatory ailments. Colony stimulating issue 1 receptor (CSF1R)-dependent macrophages and different inflammatory cells can suppress the adaptive immune system in

Anti-CXCR4 Single-Chain Variable Fragment Antibodies Have Anti-Tumor Activity
Clinical effect of rabbit anti-thymocyte globulin for chronic active antibody-mediated rejection after kidney transplantation

Clinical effect of rabbit anti-thymocyte globulin for chronic active antibody-mediated rejection after kidney transplantationClinical effect of rabbit anti-thymocyte globulin for chronic active antibody-mediated rejection after kidney transplantation

Continual energetic antibody-mediated rejection (CAAMR) is a frequent reason behind late graft loss. Nonetheless, efficient remedy for CAAMR after kidney transplantation has not but been established. Right here, we current

Isolation and characterization of a novel scFv antibody fragments specific for Hsp70 as a tumor biomarker.
Detection of Epithelial Cell Adhesion Molecule in Feline Normal and Tumor Cell Lines and Tissues With Selected Commercial Anti-human EpCAM Antibodies

Detection of Epithelial Cell Adhesion Molecule in Feline Normal and Tumor Cell Lines and Tissues With Selected Commercial Anti-human EpCAM AntibodiesDetection of Epithelial Cell Adhesion Molecule in Feline Normal and Tumor Cell Lines and Tissues With Selected Commercial Anti-human EpCAM Antibodies

Epithelial cell adhesion molecule (EpCAM) is a transmembrane protein expressed at intercellular junctions in epithelial cells. As an epithelial biomarker, it used for immunologic-based seize of epithelial-derived circulating tumor cells

A cell-free assay implicates a role of sphingomyelin and cholesterol in STING phosphorylation
Catalase activity of IgG antibodies from the sera of healthy donors and patients with schizophrenia.